The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn

244Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Fas is a cell surface protein of the tumor necrosis factor receptor, nerve growth factor receptor, CD40 family, and is involved in the control of lymphocyte apoptosis. A mutation in the Fas gene in MRL/lpr mice results in massive lymphoprolifcration (lpr) and accelerated autoimmunity. To furher study the nature of this defect, Fas mRNA expression was evaluated by reverse, transcriptase polymerase chain reaction as well as by Northern blotting. These studies revealed that the wild-type Fas message was produced at ∼10-fold lower levels in the lpr compared with the ++ substrain of MRL mice. In addition to the wild-type transcript, lpr mice also synthesized chimeric transcripts containing an insertion of the early retrotransposon (ETn). Molecular cloning and nucleotide sequencing of a Fas-ETn chimeric cDNA suggested that the striking reduction in wild-type Fas mRNA levels and the presence of aberrant transcripts in MRL/lpr mice are most likely explained by the insertion of the ETn retrotransposon into an intron of the Fas gene and induction of alternative splicing involving the 5′ ETn long terminal repeat.

Cite

CITATION STYLE

APA

Chu, J. L., Drappa, J., Parnassa, A., & Elkon, K. B. (1993). The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. Journal of Experimental Medicine, 178(2), 723–730. https://doi.org/10.1084/jem.178.2.723

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free